ONTOLOGY REPORT - ANNOTATIONS
| Term: | abnormal response/metabolism to endogenous compounds |
|
| Accession: | MP:0003638
|
browse the term
|
| Definition: | altered ability or inability to metabolize or respond to substances normally present in the body |
| Synonyms: | exact_synonym: | abnormal metabolism of endogenous compounds |
|
|
abnormal response/metabolism to endogenous compounds
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
IAGP |
11 |
105,829,261 |
105,851,259 |
RGD:5509061 |
MGI |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
IAGP |
11 |
105,829,261 |
105,851,259 |
RGD:5509061 |
MGI |
| G |
Adam8 |
a disintegrin and metallopeptidase domain 8 |
|
|
IAGP |
7 |
147,164,840 |
147,178,387 |
RGD:5509061 |
MGI |
| G |
Adora1 |
adenosine A1 receptor |
|
|
IAGP |
1 |
136,095,799 |
136,132,008 |
RGD:5509061 |
MGI |
| G |
Adora3 |
adenosine A3 receptor |
|
|
IAGP |
3 |
105,673,776 |
105,726,960 |
RGD:5509061 |
MGI |
| G |
Adora3 |
adenosine A3 receptor |
|
|
IAGP |
3 |
105,673,776 |
105,726,960 |
RGD:5509061 |
MGI |
| G |
Adora3 |
adenosine A3 receptor |
|
|
IAGP |
3 |
105,673,776 |
105,726,960 |
RGD:5509061 |
MGI |
| G |
Adrb1 |
adrenergic receptor, beta 1 |
|
|
IAGP |
19 |
56,796,862 |
56,799,352 |
RGD:5509061 |
MGI |
| G |
Adrb2 |
adrenergic receptor, beta 2 |
|
|
IAGP |
18 |
62,337,470 |
62,339,613 |
RGD:5509061 |
MGI |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
|
IAGP |
13 |
30,428,225 |
30,474,736 |
RGD:5509061 |
MGI |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
|
IAGP |
X |
21,061,752 |
21,065,957 |
RGD:5509061 |
MGI |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
|
IAGP |
X |
21,061,752 |
21,065,957 |
RGD:5509061 |
MGI |
| G |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
|
|
IAGP |
14 |
51,544,696 |
51,546,813 |
RGD:5509061 |
MGI |
| G |
Apoe |
apolipoprotein E |
|
|
IAGP |
7 |
20,281,593 |
20,284,515 |
RGD:5509061 |
MGI |
| G |
Bdkrb2 |
bradykinin receptor, beta 2 |
|
|
IAGP |
12 |
106,801,382 |
106,831,281 |
RGD:5509061 |
MGI |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
|
IAGP |
8 |
86,939,263 |
87,164,148 |
RGD:5509061 |
MGI |
| G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
|
|
IAGP |
5 |
123,183,197 |
123,214,303 |
RGD:5509061 |
MGI |
| G |
Casp8 |
caspase 8 |
|
|
IAGP |
1 |
58,852,218 |
58,904,347 |
RGD:5509061 |
MGI |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
|
IAGP |
17 |
29,227,931 |
29,237,667 |
RGD:5509061 |
MGI |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
|
IAGP |
6 |
134,870,419 |
134,875,543 |
RGD:5509061 |
MGI |
| G |
Chm |
choroidermia |
|
|
IAGP |
X |
110,154,201 |
110,299,124 |
RGD:5509061 |
MGI |
| G |
Col3a1 |
collagen, type III, alpha 1 |
|
|
IAGP |
1 |
45,368,383 |
45,406,551 |
RGD:5509061 |
MGI |
| G |
Cpa3 |
carboxypeptidase A3, mast cell |
|
|
IAGP |
3 |
20,115,515 |
20,142,080 |
RGD:5509061 |
MGI |
| G |
Ctsa |
cathepsin A |
|
|
IAGP |
2 |
164,658,373 |
164,666,532 |
RGD:5509061 |
MGI |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
|
IAGP |
15 |
74,681,440 |
74,686,748 |
RGD:5509061 |
MGI |
| G |
Ddc |
dopa decarboxylase |
|
|
IAGP |
11 |
11,714,104 |
11,798,147 |
RGD:5509061 |
MGI |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
|
IAGP |
4 |
106,964,070 |
106,979,748 |
RGD:5509061 |
MGI |
| G |
Drd1a |
dopamine receptor D1A |
|
|
IAGP |
13 |
54,146,552 |
54,151,027 |
RGD:5509061 |
MGI |
| G |
Epha1 |
Eph receptor A1 |
|
|
IAGP |
6 |
42,308,486 |
42,323,267 |
RGD:5509061 |
MGI |
| G |
Ern1 |
endoplasmic reticulum (ER) to nucleus signalling 1 |
|
|
IAGP |
11 |
106,258,934 |
106,349,110 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
|
IAGP |
10 |
5,342,780 |
5,734,495 |
RGD:5509061 |
MGI |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
|
IAGP |
12 |
77,221,406 |
77,278,246 |
RGD:5509061 |
MGI |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
|
IAGP |
12 |
77,221,406 |
77,278,246 |
RGD:5509061 |
MGI |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
|
IAGP |
12 |
77,221,406 |
77,278,246 |
RGD:5509061 |
MGI |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
|
IAGP |
12 |
77,221,406 |
77,278,246 |
RGD:5509061 |
MGI |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
|
IAGP |
12 |
77,221,406 |
77,278,246 |
RGD:5509061 |
MGI |
| G |
Fabp7 |
fatty acid binding protein 7, brain |
|
|
IAGP |
10 |
57,504,729 |
57,508,256 |
RGD:5509061 |
MGI |
| G |
Foxn1 |
forkhead box N1 |
|
|
IAGP |
11 |
78,171,790 |
78,200,060 |
RGD:5509061 |
MGI |
| G |
Foxq1 |
forkhead box Q1 |
|
|
IAGP |
13 |
31,650,039 |
31,652,845 |
RGD:5509061 |
MGI |
| G |
Ghsr |
growth hormone secretagogue receptor |
|
|
IAGP |
3 |
27,270,273 |
27,276,932 |
RGD:5509061 |
MGI |
| G |
Ghsr |
growth hormone secretagogue receptor |
|
|
IAGP |
3 |
27,270,273 |
27,276,932 |
RGD:5509061 |
MGI |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 |
|
|
IAGP |
9 |
107,516,469 |
107,537,673 |
RGD:5509061 |
MGI |
| G |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
|
|
IAGP |
2 |
174,109,821 |
174,172,245 |
RGD:5509061 |
MGI |
| G |
Gpc1 |
glypican 1 |
|
|
IAGP |
1 |
94,728,263 |
94,756,773 |
RGD:5509061 |
MGI |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
|
IAGP |
5 |
139,899,133 |
139,903,754 |
RGD:5509061 |
MGI |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
|
IAGP |
5 |
139,899,133 |
139,903,754 |
RGD:5509061 |
MGI |
| G |
Grpr |
gastrin releasing peptide receptor |
|
|
IAGP |
X |
159,951,836 |
159,987,579 |
RGD:5509061 |
MGI |
| G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
|
|
IAGP |
17 |
34,400,172 |
34,406,363 |
RGD:5509061 |
MGI |
| G |
H2-T23 |
histocompatibility 2, T region locus 23 |
|
|
IAGP |
17 |
36,166,922 |
36,169,646 |
RGD:5509061 |
MGI |
| G |
Hrh1 |
histamine receptor H1 |
|
|
IAGP |
6 |
114,347,930 |
114,433,290 |
RGD:5509061 |
MGI |
| G |
Hspa1b |
heat shock protein 1B |
|
|
IAGP |
17 |
35,093,374 |
35,096,183 |
RGD:5509061 |
MGI |
| G |
Hspa1b |
heat shock protein 1B |
|
|
IAGP |
17 |
35,093,374 |
35,096,183 |
RGD:5509061 |
MGI |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C |
|
|
IAGP |
X |
143,397,056 |
143,631,820 |
RGD:5509061 |
MGI |
| G |
Ikbkg |
inhibitor of kappaB kinase gamma |
|
|
IAGP |
X |
71,638,630 |
71,699,117 |
RGD:5509061 |
MGI |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
|
IAGP |
1 |
40,281,925 |
40,373,022 |
RGD:5509061 |
MGI |
| G |
Il20rb |
interleukin 20 receptor beta |
|
|
IAGP |
9 |
100,358,138 |
100,386,892 |
RGD:5509061 |
MGI |
| G |
Il23r |
interleukin 23 receptor |
|
|
IAGP |
6 |
67,372,926 |
67,441,849 |
RGD:5509061 |
MGI |
| G |
Itgb6 |
integrin beta 6 |
|
|
IAGP |
2 |
60,436,349 |
60,560,660 |
RGD:5509061 |
MGI |
| G |
Kat6a |
K(lysine) acetyltransferase 6A |
|
|
IAGP |
8 |
23,970,011 |
24,053,734 |
RGD:5509061 |
MGI |
| G |
Kiss1r |
KISS1 receptor |
|
|
IAGP |
10 |
79,379,716 |
79,385,018 |
RGD:5509061 |
MGI |
| G |
Kit |
kit oncogene |
|
|
IAGP |
5 |
75,971,012 |
76,052,747 |
RGD:5509061 |
MGI |
| G |
Kit |
kit oncogene |
|
|
IAGP |
5 |
75,971,012 |
76,052,747 |
RGD:5509061 |
MGI |
| G |
Kit |
kit oncogene |
|
|
IAGP |
5 |
75,971,012 |
76,052,747 |
RGD:5509061 |
MGI |
| G |
Ldlr |
low density lipoprotein receptor |
|
|
IAGP |
9 |
21,528,038 |
21,554,363 |
RGD:5509061 |
MGI |
| G |
Lepr |
leptin receptor |
|
|
IAGP |
4 |
101,390,012 |
101,487,959 |
RGD:5509061 |
MGI |
| G |
Lepr |
leptin receptor |
|
|
IAGP |
4 |
101,390,012 |
101,487,959 |
RGD:5509061 |
MGI |
| G |
Lrp2 |
low density lipoprotein receptor-related protein 2 |
|
|
IAGP |
2 |
69,262,392 |
69,424,124 |
RGD:5509061 |
MGI |
| G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
|
IAGP |
15 |
91,503,655 |
91,646,555 |
RGD:5509061 |
MGI |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
IAGP |
2 |
164,773,751 |
164,781,346 |
RGD:5509061 |
MGI |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
|
IAGP |
12 |
4,247,362 |
4,484,060 |
RGD:5509061 |
MGI |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IAGP |
5 |
23,870,637 |
23,890,292 |
RGD:5509061 |
MGI |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
|
IAGP |
1 |
173,144,101 |
173,148,975 |
RGD:5509061 |
MGI |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
|
IAGP |
2 |
56,959,637 |
56,976,414 |
RGD:5509061 |
MGI |
| G |
Nt5e |
5' nucleotidase, ecto |
|
|
IAGP |
9 |
88,222,447 |
88,266,927 |
RGD:5509061 |
MGI |
| G |
Nt5e |
5' nucleotidase, ecto |
|
|
IAGP |
9 |
88,222,447 |
88,266,927 |
RGD:5509061 |
MGI |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled 2 |
|
|
IAGP |
7 |
108,145,086 |
108,160,505 |
RGD:5509061 |
MGI |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled 2 |
|
|
IAGP |
7 |
108,145,086 |
108,160,505 |
RGD:5509061 |
MGI |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled 2 |
|
|
IAGP |
7 |
108,145,086 |
108,160,505 |
RGD:5509061 |
MGI |
| G |
Pah |
phenylalanine hydroxylase |
|
|
IAGP |
10 |
86,984,540 |
87,046,882 |
RGD:5509061 |
MGI |
| G |
Pbx1 |
pre B cell leukemia homeobox 1 |
|
|
IAGP |
1 |
170,049,495 |
170,362,389 |
RGD:5509061 |
MGI |
| G |
Pdc |
phosducin |
|
|
IAGP |
1 |
152,166,547 |
152,181,036 |
RGD:5509061 |
MGI |
| G |
Pdyn |
prodynorphin |
|
|
IAGP |
2 |
129,513,737 |
129,515,604 |
RGD:5509061 |
MGI |
| G |
Pgr |
progesterone receptor |
|
|
IAGP |
9 |
8,899,833 |
8,968,611 |
RGD:5509061 |
MGI |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
|
IAGP |
1 |
151,676,752 |
151,808,414 |
RGD:5509061 |
MGI |
| G |
Pld2 |
phospholipase D2 |
|
|
IAGP |
11 |
70,353,666 |
70,371,612 |
RGD:5509061 |
MGI |
| G |
Pomc |
pro-opiomelanocortin-alpha |
|
|
IAGP |
12 |
3,954,951 |
3,960,618 |
RGD:5509061 |
MGI |
| G |
Prcp |
prolylcarboxypeptidase (angiotensinase C) |
|
|
IAGP |
7 |
100,023,763 |
100,083,091 |
RGD:5509061 |
MGI |
| G |
Pros1 |
protein S (alpha) |
|
|
IAGP |
16 |
62,854,160 |
62,929,166 |
RGD:5509061 |
MGI |
| G |
Ptf1a |
pancreas specific transcription factor, 1a |
|
|
IAGP |
2 |
19,367,290 |
19,369,128 |
RGD:5509061 |
MGI |
| G |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
|
|
IAGP |
3 |
157,229,856 |
157,307,722 |
RGD:5509061 |
MGI |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
|
IAGP |
2 |
36,085,946 |
36,107,789 |
RGD:5509061 |
MGI |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
|
IAGP |
1 |
151,947,254 |
151,955,147 |
RGD:5509061 |
MGI |
| G |
Pyy |
peptide YY |
|
|
IAGP |
11 |
101,967,990 |
101,969,090 |
RGD:5509061 |
MGI |
| G |
Ramp2 |
receptor (calcitonin) activity modifying protein 2 |
|
|
IAGP |
11 |
101,107,648 |
101,109,564 |
RGD:5509061 |
MGI |
| G |
Rb1 |
retinoblastoma 1 |
|
|
IAGP |
14 |
73,595,309 |
73,725,598 |
RGD:5509061 |
MGI |
| G |
Reg2 |
regenerating islet-derived 2 |
|
|
IAGP |
6 |
78,355,149 |
78,358,091 |
RGD:5509061 |
MGI |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
|
IAGP |
19 |
5,637,490 |
5,648,130 |
RGD:5509061 |
MGI |
| G |
Rnls |
renalase, FAD-dependent amine oxidase |
|
|
IAGP |
19 |
33,212,234 |
33,466,785 |
RGD:5509061 |
MGI |
| G |
S100a10 |
S100 calcium binding protein A10 (calpactin) |
|
|
IAGP |
3 |
93,359,039 |
93,368,567 |
RGD:5509061 |
MGI |
| G |
Sct |
secretin |
|
|
IAGP |
7 |
148,464,237 |
148,465,030 |
RGD:5509061 |
MGI |
| G |
Sctr |
secretin receptor |
|
|
IAGP |
1 |
121,903,557 |
121,960,111 |
RGD:5509061 |
MGI |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
|
IAGP |
13 |
73,674,195 |
73,716,120 |
RGD:5509061 |
MGI |
| G |
Slc9a3r1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 |
|
|
IAGP |
11 |
115,024,655 |
115,042,492 |
RGD:5509061 |
MGI |
| G |
Slc9a3r2 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 |
|
|
IAGP |
17 |
24,776,227 |
24,787,250 |
RGD:5509061 |
MGI |
| G |
Stk3 |
serine/threonine kinase 3 |
|
|
IAGP |
15 |
34,805,254 |
35,085,561 |
RGD:5509061 |
MGI |
| G |
Stk4 |
serine/threonine kinase 4 |
|
|
IAGP |
2 |
163,899,914 |
163,981,257 |
RGD:5509061 |
MGI |
| G |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
|
|
IAGP |
19 |
55,816,300 |
56,008,145 |
RGD:5509061 |
MGI |
| G |
Thra |
thyroid hormone receptor alpha |
|
|
IAGP |
11 |
98,603,187 |
98,626,425 |
RGD:5509061 |
MGI |
| G |
Thra |
thyroid hormone receptor alpha |
|
|
IAGP |
11 |
98,603,187 |
98,626,425 |
RGD:5509061 |
MGI |
| G |
Thrb |
thyroid hormone receptor beta |
|
|
IAGP |
14 |
18,493,474 |
18,870,602 |
RGD:5509061 |
MGI |
| G |
Thrb |
thyroid hormone receptor beta |
|
|
IAGP |
14 |
18,493,474 |
18,870,602 |
RGD:5509061 |
MGI |
| G |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
|
|
IAGP |
10 |
18,720,716 |
18,735,216 |
RGD:5509061 |
MGI |
| G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a |
|
|
IAGP |
1 |
107,677,300 |
107,744,558 |
RGD:5509061 |
MGI |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
|
IAGP |
14 |
61,582,671 |
61,665,692 |
RGD:5509061 |
MGI |
| G |
Ttn |
titin |
|
|
IAGP |
2 |
76,542,041 |
76,820,604 |
RGD:5509061 |
MGI |
| G |
Xirp2 |
xin actin-binding repeat containing 2 |
|
|
IAGP |
2 |
67,284,059 |
67,364,663 |
RGD:5509061 |
MGI |
| Q |
Tilss1_m |
TNF-induced lethal shock susceptibility 1 (mouse) |
|
|
IAGP |
6 |
93,909,916 |
127,910,059 |
RGD:5509061 |
MGI |
| Q |
Tilss3_m |
TNF-induced lethal shock susceptibility 3 (mouse) |
|
|
IAGP |
17 |
67,734,943 |
95,257,958 |
RGD:5509061 |
MGI |
| Q |
Tnfp_m |
tumor necrosis factor protection (mouse) |
|
|
IAGP |
|
|
|
RGD:5509061 |
MGI |
abnormal response to vitamins
|
| G |
Kcp |
kielin/chordin-like protein |
|
|
IAGP |
6 |
29,432,036 |
29,457,934 |
RGD:5509061 |
MGI |
| G |
Lasp1 |
LIM and SH3 protein 1 |
|
|
IAGP |
11 |
97,660,986 |
97,700,078 |
RGD:5509061 |
MGI |
| G |
Rarg |
retinoic acid receptor, gamma |
|
|
IAGP |
15 |
102,065,371 |
102,087,914 |
RGD:5509061 |
MGI |
| G |
Tgif1 |
TGFB-induced factor homeobox 1 |
|
|
IAGP |
17 |
71,193,545 |
71,202,872 |
RGD:5509061 |
MGI |
| G |
Vdr |
vitamin D receptor |
|
|
IAGP |
15 |
97,684,858 |
97,738,727 |
RGD:5509061 |
MGI |
insensitivity to growth hormone
|
| G |
Hdac2 |
histone deacetylase 2 |
|
|
IAGP |
10 |
36,694,350 |
36,721,694 |
RGD:5509061 |
MGI |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
IAGP |
10 |
87,321,801 |
87,399,792 |
RGD:5509061 |
MGI |
insensitivity to parathyroid hormone
|
| G |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
|
|
IAGP |
2 |
174,109,821 |
174,172,245 |
RGD:5509061 |
MGI |
Term paths to the root
|